ALK INHIBITORS

被引：0
|
作者：
Blackhall, F. [1 ]
机构：
[1] Christie NHS Fdn Trust, Manchester, Lancs, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S20 / S21
页数：2
相关论文
共 50 条
  • [41] ALK Inhibitors in Nonsmall Cell Lung Cancer
    Garg, Nitish
    Kothari, Rushabh
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (01) : 67 - 70
  • [42] Recent Advances in ALK2 Inhibitors
    Rooney, Lisa
    Jones, Chris
    ACS OMEGA, 2021, 6 (32): : 20729 - 20734
  • [43] ALK inhibitors: plateauing systemic and intracranial activity?
    Costa, Daniel B.
    LANCET ONCOLOGY, 2016, 17 (04): : 404 - 406
  • [44] Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors
    Yang, Dafu
    Li, Dan
    Dai, Zhaoxia
    Ma, Yutong
    Ou, Qiuxiang
    Wu, Xue
    Cui, Saiqiong
    CANCER COMMUNICATIONS, 2021, 41 (02) : 183 - 186
  • [45] Sequencing of ALK Inhibitors in ALK+ Non-Small Cell Lung Cancer
    Shirish M. Gadgeel
    Current Treatment Options in Oncology, 2017, 18
  • [46] Clinical development and approval of second generation ALK inhibitors for ALK rearranged lung cancer
    Costa, Daniel B.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (06) : 373 - 375
  • [47] Treatment beyond disease progression: ALK inhibitors in ALK-rearranged advanced NSCLC
    Leighl, N. B.
    Kuo, J.
    Pavel, A.
    Prescilla, M.
    Shepherd, F. A.
    Liu, G.
    Bradbury, P.
    Moskovits, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Atypical Lung Carcinoids with EML4-ALK Fusion and Responses to ALK Inhibitors
    Waliany, Sarah
    Hung, Yin P.
    Abu Rous, Fawzi
    Do, Andrew
    Peterson, Jennifer
    Meservey, Caitlin
    Digumarthy, Subba R.
    Gadgeel, Shirish M.
    Lin, Jessica J.
    Meadori, Catherine B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E32 - E33
  • [49] ALK ALTERATIONS IN A SERIES OF 62 GLIOBLASTOMA CASES: IS THERE A THERAPEUTIC ROLE FOR ALK INHIBITORS MOLECULES?
    Carrato, Cristina
    Munoz-Marmol, Ana
    Serrano, Laia
    Pijuan, Lara
    Hostalot, Cristina
    Villa, Saand Lvador
    Ariza, Aurelio
    Etxaniz, Olatz
    Balana, Carmen
    NEURO-ONCOLOGY, 2013, 15 : 12 - 13
  • [50] Using ALK IHC test to identify potential responders to ALK inhibitors outside of NSCLC
    Xiu, J.
    Gatalica, Z.
    Abbott, B.
    Reddy, S.
    Vanderwalde, A.
    Braiteh, F.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S32 - S32
12345